State of Wisconsin Investment Board’s Palvella Therapeutics PVLA Stock Holding History

State of Wisconsin Investment Board’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$739K	Buy	5,929 +1,416	+31%	+$148K	﹤0.01%	1822
2025 Q4	$472K	Buy	+4,513	New	+$385K	﹤0.01%	1977
2020 Q1	–	Sell	-890	Closed	-$258K	–	1743
2019 Q4	$258K	Hold	890	–	–	﹤0.01%	1560
2019 Q3	$243K	Hold	890	–	–	﹤0.01%	1484
2019 Q2	$335K	Buy	890 +20	+2%	+$5.97K	﹤0.01%	1424
2019 Q1	$233K	Buy	870 +199	+30%	+$47.3K	﹤0.01%	1445
2018 Q4	$143K	Buy	671 +346	+106%	+$107K	﹤0.01%	1477
2018 Q3	$146K	Hold	325	–	–	﹤0.01%	1513
2018 Q2	$132K	Hold	325	–	–	﹤0.01%	1447
2018 Q1	$177K	Hold	325	–	–	﹤0.01%	1405
2017 Q4	$196K	Hold	325	–	–	﹤0.01%	1389
2017 Q3	$150K	Hold	325	–	–	﹤0.01%	1419
2017 Q2	$132K	Buy	+325	New	+$95K	﹤0.01%	1428

Other funds holding PVLA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State of Wisconsin Investment Board's PVLA Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Palvella Therapeutics (PVLA) stake by 31% in Q1 2026, buying an estimated $148K and bringing the position to 5,929 shares worth $739K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

State of Wisconsin Investment Board first reported a position in PVLA in Q2 2017 and has held it in 13 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

State of Wisconsin Investment Board held 5,929 shares of Palvella Therapeutics worth $739K as of Q1 2026.
State of Wisconsin Investment Board bought 1,416 Palvella Therapeutics shares in Q1 2026, an estimated $148K.
Palvella Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1822 holding.
State of Wisconsin Investment Board first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 13 quarters since.
180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.